Morgan Stanley (NYSE:MS) Announces Quarterly Earnings Results

Morgan Stanley (NYSE:MS) issued its earnings results on Thursday. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.10, RTT News reports. The business had revenue of $10.24 billion during the quarter, compared to analyst estimates of $10.02 billion. Morgan Stanley had a return on equity of 11.10% and a net margin of 16.06%. Morgan Stanley’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.30 earnings per share.

Shares of MS stock opened at $44.39 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 2.60. Morgan Stanley has a fifty-two week low of $36.74 and a fifty-two week high of $51.53. The company has a 50 day moving average of $43.34. The company has a market capitalization of $74.74 billion, a P/E ratio of 9.63, a P/E/G ratio of 1.18 and a beta of 1.31.

A number of hedge funds have recently made changes to their positions in the business. Nalls Sherbakoff Group LLC bought a new position in shares of Morgan Stanley during the fourth quarter valued at approximately $28,000. Liberty Wealth Management LLC bought a new position in shares of Morgan Stanley during the fourth quarter valued at approximately $29,000. IMA Wealth Inc. bought a new position in shares of Morgan Stanley during the first quarter valued at approximately $31,000. Citizens Financial Group Inc RI raised its holdings in shares of Morgan Stanley by 46.2% during the first quarter. Citizens Financial Group Inc RI now owns 775 shares of the financial services provider’s stock valued at $32,000 after acquiring an additional 245 shares in the last quarter. Finally, Destination Wealth Management raised its holdings in shares of Morgan Stanley by 38.7% during the first quarter. Destination Wealth Management now owns 771 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 215 shares in the last quarter. Hedge funds and other institutional investors own 83.87% of the company’s stock.

Several brokerages have issued reports on MS. Royal Bank of Canada set a GBX 5,200 ($67.95) target price on London Stock Exchange Group and gave the stock a “buy” rating in a research note on Wednesday, April 24th. ValuEngine downgraded Zumiez from a “hold” rating to a “sell” rating in a research report on Monday, May 13th. Citigroup upgraded Infosys from a “neutral” rating to a “buy” rating in a research report on Friday, July 12th. Oppenheimer set a $15.00 price objective on Strongbridge Biopharma and gave the company a “buy” rating in a research report on Tuesday, March 26th. Finally, BMO Capital Markets lowered their price objective on Pentair to $39.00 and set a “market perform” rating for the company in a research report on Thursday, April 18th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and ten have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $56.69.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Article: What is a short straddle?

Earnings History for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.